EDGAR Filing Documents for 0000950136-07-008331

Form 8-K - Current report:

SEC Accession No. 0000950136-07-008331

Filing Date

2007-12-11

Accepted

2007-12-11 16:28:58

Documents

Period of Report

2007-12-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	file1.htm	8-K	27641
2	WARRANT	file2.htm	EX-4.1	67393
3	REGISTRATION RIGHTS AGREEMENT	file3.htm	EX-4.2	61441
4	COMMON STOCK PURCHASE AGREEMENT	file4.htm	EX-10.1	338438
5	PRESS RELEASE	file5.htm	EX-99.1	20833
6		press.jpg	GRAPHIC	4861
7		cyclacel.jpg	GRAPHIC	11944
	Complete submission text file	0000950136-07-008331.txt		540916

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)